Xalles Holdings Inc (XALL)

[BIOCHEMUP]

XALL market cap as of end of may 2020: $4,3 million. Going into the last month of Q2, shareholders will be extremely rewarded if they hold on to their XALL shares atleast two quarters. During Q2 we had asset appreciation through all of these acquisitions as of lately, in Q3 and Q4 we should see not only more acquisitions but also a large increase in revenue as a result of the synergies between current subsidiaries. MinervaWorks, Intel365 and Argus especially. PPS will move up in a serious way once we have new signed partnerships and contracts. We could be sitting at a nickel or flirting with a dime in a relatively short period of time.